bluebird bio, Inc. (0HOH.L)

USD 9.28

(33.91%)

Long Term Debt Summary of bluebird bio, Inc.

  • bluebird bio, Inc.'s latest annual long term debt in 2023 was 224.41 Million USD , down -2.52% from previous year.
  • bluebird bio, Inc.'s latest quarterly long term debt in 2024 Q1 was 206.77 Million USD , down 0.0% from previous quarter.
  • bluebird bio, Inc. reported annual long term debt of 230.23 Million USD in 2022, up 246.56% from previous year.
  • bluebird bio, Inc. reported annual long term debt of 66.43 Million USD in 2021, down -60.46% from previous year.
  • bluebird bio, Inc. reported quarterly long term debt of 194.19 Million USD for 2024 Q2, down 0.0% from previous quarter.
  • bluebird bio, Inc. reported quarterly long term debt of 224.41 Million USD for 2023 Q4, down -3.28% from previous quarter.

Annual Long Term Debt Chart of bluebird bio, Inc. (2023 - 2011)

Historical Annual Long Term Debt of bluebird bio, Inc. (2023 - 2011)

Year Long Term Debt Long Term Debt Growth
2023 224.41 Million USD -2.52%
2022 230.23 Million USD 246.56%
2021 66.43 Million USD -60.46%
2020 167.99 Million USD -1.65%
2019 170.81 Million USD 11.41%
2018 153.31 Million USD -0.92%
2017 154.74 Million USD 28.81%
2016 120.14 Million USD 94.08%
2015 61.9 Million USD 613.64%
2014 8.67 Million USD 28.69%
2013 6.74 Million USD 0.0%
2012 - USD 0.0%
2011 - USD 0.0%

Peer Long Term Debt Comparison of bluebird bio, Inc.

Name Long Term Debt Long Term Debt Difference
Editas Medicine, Inc. 24.37 Million USD -820.807%
Dynavax Technologies Corporation 252.41 Million USD 11.092%
Supernus Pharmaceuticals, Inc. 33.19 Million USD -576.042%
Perrigo Company plc 3.63 Billion USD 93.822%
Illumina, Inc. 1.48 Billion USD 84.928%
Thermo Fisher Scientific Inc. 31.3 Billion USD 99.283%
Iovance Biotherapeutics, Inc. 1 Million USD -22341.9%
Walgreens Boots Alliance, Inc. 8.04 Billion USD 97.21%
IQVIA Holdings Inc. 12.95 Billion USD 98.268%
Heron Therapeutics, Inc. 173.75 Million USD -29.16%
Regeneron Pharmaceuticals, Inc. 2.7 Billion USD 91.697%
Unity Biotechnology, Inc. 23.53 Million USD -853.392%
Waters Corporation 2.3 Billion USD 90.266%
Biogen Inc. 7.18 Billion USD 96.878%
Sangamo Therapeutics, Inc. 33.51 Million USD -569.608%
Evolus, Inc. 120.35 Million USD -86.458%
Adicet Bio, Inc. 17.7 Million USD -1167.689%
Cara Therapeutics, Inc. 37.07 Million USD -505.246%
Esperion Therapeutics, Inc. 501.54 Million USD 55.255%
FibroGen, Inc. 89.69 Million USD -150.197%
Agilent Technologies, Inc. 2.73 Billion USD 91.795%
Corbus Pharmaceuticals Holdings, Inc. 3.23 Million USD -6829.44%
Homology Medicines, Inc. 43.17 Million USD -419.777%
Geron Corporation 35.05 Million USD -540.264%
Alnylam Pharmaceuticals, Inc. 2.34 Billion USD 90.422%
Amicus Therapeutics, Inc. 387.85 Million USD 42.139%
Myriad Genetics, Inc. 130.9 Million USD -71.443%
Viking Therapeutics, Inc. 936 Thousand USD -23876.389%
Intellia Therapeutics, Inc. 96.74 Million USD -131.965%
Zoetis Inc. 6.56 Billion USD 96.581%
Abeona Therapeutics Inc. 4.4 Million USD -4998.114%
Mettler-Toledo International Inc. 1.97 Billion USD 88.64%
BioMarin Pharmaceutical Inc. 593.09 Million USD 62.161%
Vertex Pharmaceuticals Incorporated 724.7 Million USD 69.033%
Kala Pharmaceuticals, Inc. 34.19 Million USD -556.388%
Ionis Pharmaceuticals, Inc. 1.4 Billion USD 83.974%
Atara Biotherapeutics, Inc. 45.69 Million USD -391.145%
Verastem, Inc. 40.08 Million USD -459.844%
Nektar Therapeutics 112.62 Million USD -99.262%
Axsome Therapeutics, Inc. 178.07 Million USD -26.029%
Aclaris Therapeutics, Inc. 3.07 Million USD -7200.553%
Sarepta Therapeutics, Inc. 1.13 Billion USD 80.184%
OPKO Health, Inc. 222.03 Million USD -1.074%
Exelixis, Inc. 189.94 Million USD -18.15%
Neurocrine Biosciences, Inc. 258.3 Million USD 13.117%
Corcept Therapeutics Incorporated - USD -Infinity%
Anavex Life Sciences Corp. - USD -Infinity%
uniQure N.V. 130.06 Million USD -72.544%
Imunon, Inc. 1.13 Million USD -19598.093%
Blueprint Medicines Corporation 610.96 Million USD 63.268%
Insmed Incorporated 1.19 Billion USD 81.194%
Halozyme Therapeutics, Inc. 1.49 Billion USD 85.031%
Agios Pharmaceuticals, Inc. 56.98 Million USD -293.8%
TG Therapeutics, Inc. 100.11 Million USD -124.154%
Incyte Corporation 29.16 Million USD -669.56%
Emergent BioSolutions Inc. 446.5 Million USD 49.738%